Albemarle Corporation (ALB) 10-Year Financial Performance & Capital Metrics

ALB • • Industrial / General

Basic MaterialsSpecialty ChemicalsCatalysts & Process ChemicalsRefining & Petrochemical Catalysts

AboutAlbemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.Show more

Revenue $5.38B -44.1%
EBITDA -$1.19B -274.2%
Net Income -$1.18B -175.0%
EPS (Diluted) -11.20 -183.8%
Gross Margin 1.57% -87.4%
EBITDA Margin -22.09% -411.6%
Operating Margin -33.04% -1361.4%
Net Margin -21.93% -234.1%
ROE -11.87% -167.4%
ROIC -10.38% -733.5%
Debt/Equity 0.35 -20.0%
Interest Coverage -10.73 -594.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓14 consecutive years of dividend growth
✓Momentum leader: RS Rating 95 (top 5%)
✓Trading near 52-week high

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y8.2%

5Y8.42%

3Y17.35%

TTM-23.92%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM98.87%

EPS CAGR

10Y-

5Y-

3Y-

TTM90.49%

ROCE

10Y Avg7.25%

5Y Avg5.46%

3Y Avg4.13%

Latest-12.1%

Peer Comparison

Refining & Petrochemical Catalysts

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
IOSPInnospec Inc.	2.03B	81.89	57.67	-5.31%	-0.07%	-0.09%	7.05%	0.04
MTXMinerals Technologies Inc.	2.11B	67.64	13.08	-2.37%	-0.08%	-0.09%	6.98%	0.57
CBTCabot Corporation	3.89B	73.56	12.22	-7.04%	8.91%	19.67%	10.05%	0.66
SSLSasol Limited	4.51B	7.15	0.68	-9.46%	-7.15%	-23.8%	100%	0.77
ALBAlbemarle Corporation	20.45B	173.78	-15.52	-44.08%	-0.43%	-0.21%		0.35
ECVTEcovyst Inc.	1.23B	10.79	-179.83	1.94%	-14.33%	-17.66%	6.58%	1.28

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	3.65B	2.68B	3.07B	3.37B	3.59B	3.13B	3.33B	7.32B	9.62B	5.38B
Revenue Growth %	0.49%	-0.27%	0.15%	0.1%	0.06%	-0.13%	0.06%	1.2%	0.31%	-0.44%
Cost of Goods Sold+	2.45B	1.71B	1.96B	2.16B	2.33B	2.13B	2.32B	4.24B	8.42B	5.29B
COGS % of Revenue	0.67%	0.64%	0.64%	0.64%	0.65%	0.68%	0.7%	0.58%	0.88%	0.98%
Gross Profit+	1.2B	970.58M	1.11B	1.22B	1.26B	996.85M	1.01B	3.08B	1.2B	84.24M
Gross Margin %	0.33%	0.36%	0.36%	0.36%	0.35%	0.32%	0.3%	0.42%	0.12%	0.02%
Gross Profit Growth %	0.55%	-0.19%	0.14%	0.1%	0.03%	-0.21%	0.01%	2.05%	-0.61%	-0.93%
Operating Expenses+	515.12M	369.33M	534.62M	305.72M	592.36M	491.04M	210.04M	607.73M	945.03M	1.86B
OpEx % of Revenue	0.14%	0.14%	0.17%	0.09%	0.17%	0.16%	0.06%	0.08%	0.1%	0.35%
Selling, General & Admin	300.44M	353.76M	450.29M	446.09M	0	0	0	0	0	0
SG&A % of Revenue	0.08%	0.13%	0.15%	0.13%	-	-	-	-	-	-
Research & Development	102.87M	80.47M	84.33M	70.05M	58.29M	59.21M	54.03M	71.98M	85.72M	86.72M
R&D % of Revenue	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	0.01%	0.01%	0.02%
Other Operating Expenses	125.5M	-64.91M	0	-210.43M	534.07M	431.83M	156.01M	535.75M	859.3M	1.77B
Operating Income+	345.11M	600.98M	571.66M	911.54M	666.12M	505.81M	798.43M	2.47B	251.88M	-1.78B
Operating Margin %	0.09%	0.22%	0.19%	0.27%	0.19%	0.16%	0.24%	0.34%	0.03%	-0.33%
Operating Income Growth %	0.27%	0.74%	-0.05%	0.59%	-0.27%	-0.24%	0.58%	2.09%	-0.9%	-8.05%
EBITDA+	605.19M	827.15M	768.59M	1.11B	879.61M	737.8M	1.05B	2.77B	681.83M	-1.19B
EBITDA Margin %	0.17%	0.31%	0.25%	0.33%	0.25%	0.24%	0.32%	0.38%	0.07%	-0.22%
EBITDA Growth %	0.61%	0.37%	-0.07%	0.45%	-0.21%	-0.16%	0.43%	1.63%	-0.75%	-2.74%
D&A (Non-Cash Add-back)	260.08M	226.17M	196.93M	200.7M	213.48M	231.98M	254M	300.84M	429.94M	588.64M
EBIT	392.39M	580.45M	646.62M	749.68M	729.77M	510.47M	621.13M	2.57B	467.11M	-597.75M
Net Interest Income+	-81.65M	-65.18M	-115.35M	-52.41M	-57.7M	-73.12M	-61.48M	-122.97M	-116.07M	-165.62M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	81.65M	65.18M	115.35M	52.41M	57.7M	73.12M	61.48M	122.97M	116.07M	165.62M
Other Income/Expense	-6.39M	-85.72M	-124.86M	-116.84M	26.39M	-4.77M	-569.05M	735.66M	1.85B	728.15M
Pretax Income+	358.19M	515.26M	446.8M	794.7M	692.52M	501.04M	229.39M	3.21B	2.1B	-1.05B
Pretax Margin %	0.1%	0.19%	0.15%	0.24%	0.19%	0.16%	0.07%	0.44%	0.22%	-0.19%
Income Tax+	11.13M	96.26M	431.82M	144.83M	88.16M	54.42M	29.45M	390.59M	430.28M	87.08M
Effective Tax Rate %	0.94%	1.25%	0.12%	0.87%	0.77%	0.75%	0.54%	0.84%	0.75%	1.13%
Net Income+	334.91M	643.67M	54.85M	693.56M	533.23M	375.76M	123.67M	2.69B	1.57B	-1.18B
Net Margin %	0.09%	0.24%	0.02%	0.21%	0.15%	0.12%	0.04%	0.37%	0.16%	-0.22%
Net Income Growth %	1.51%	0.92%	-0.91%	11.64%	-0.23%	-0.3%	-0.67%	20.75%	-0.42%	-1.75%
Net Income (Continuing)	327.59M	478.64M	99.47M	739.14M	604.36M	446.62M	199.94M	2.82B	1.67B	-1.14B
Discontinued Operations	32.48M	202.13M	0	0	0	0	0	0	0	0
Minority Interest	146.92M	147.54M	143.15M	173.79M	161.33M	200.37M	180.34M	208.22M	252.92M	238.17M
EPS (Diluted)+	3.00	5.68	0.49	6.34	5.02	3.52	1.06	22.84	13.36	-11.20
EPS Growth %	0.78%	0.89%	-0.91%	11.94%	-0.21%	-0.3%	-0.7%	20.55%	-0.42%	-1.84%
EPS (Basic)	3.01	5.73	0.49	6.40	5.03	3.53	1.07	22.97	13.41	-11.20
Diluted Shares Outstanding	111.56M	113.24M	112.38M	109.46M	106.32M	106.81M	116.54M	117.79M	117.77M	117.52M
Basic Shares Outstanding	111.18M	112.38M	110.91M	108.43M	105.95M	106.4M	115.84M	117.12M	117.32M	117.52M
Dividend Payout Ratio	0.36%	0.21%	2.56%	0.21%	0.29%	0.43%	1.44%	0.07%	0.12%	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.83B	3.31B	2.48B	2B	2.23B	2.21B	1.99B	5.19B	5.22B	3.84B
Cash & Short-Term Investments	213.73M	2.27B	1.14B	555.32M	613.11M	746.72M	439.27M	1.5B	889.9M	1.19B
Cash Only	213.73M	2.27B	1.14B	555.32M	613.11M	746.72M	439.27M	1.5B	889.9M	1.19B
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	495.55M	543.11M	619.39M	697.89M	752.45M	530.84M	700.06M	1.45B	1.84B	1.07B
Days Sales Outstanding	49.54	74.04	73.59	75.48	76.51	61.92	76.78	72.23	69.65	72.33
Inventory	508.73M	450.26M	592.78M	700.54M	768.98M	750.24M	798.62M	2.08B	2.16B	1.5B
Days Inventory Outstanding	75.65	96.3	110.28	118.5	120.41	128.44	125.67	178.62	93.69	103.61
Other Current Assets	643.6M	1.25M	41.74M	1.5M	6.93M	120.85M	5.8M	6.72M	6.59M	4.75M
Total Non-Current Assets+	7.78B	4.85B	5.27B	5.58B	7.64B	8.24B	8.98B	10.27B	13.05B	12.77B
Property, Plant & Equipment	2.48B	2.36B	2.49B	3.02B	5.04B	5.35B	6.06B	7.09B	9.63B	9.45B
Fixed Asset Turnover	1.47x	1.13x	1.23x	1.12x	0.71x	0.58x	0.55x	1.03x	1.00x	0.57x
Goodwill	2.89B	1.54B	1.61B	1.57B	1.58B	1.67B	1.6B	1.62B	1.63B	1.58B
Intangible Assets	1.73B	354.56M	421.5M	386.14M	354.62M	349.11M	308.95M	287.87M	261.86M	230.75M
Long-Term Investments	455.42M	457.53M	534.06M	528.72M	579.81M	656.24M	912.01M	1.15B	1.38B	1.12B
Other Non-Current Assets	140.97M	81.19M	188.87M	63.11M	63.92M	198.95M	78.7M	75.95M	125.55M	332.26M
Total Assets+	9.62B	8.16B	7.75B	7.58B	9.86B	10.45B	10.97B	15.46B	18.27B	16.61B
Asset Turnover	0.38x	0.33x	0.40x	0.45x	0.36x	0.30x	0.30x	0.47x	0.53x	0.32x
Asset Growth %	0.84%	-0.15%	-0.05%	-0.02%	0.3%	0.06%	0.05%	0.41%	0.18%	-0.09%
Total Current Liabilities+	1.62B	1.14B	1.2B	1.18B	1.41B	1.8B	1.87B	2.74B	3.56B	1.97B
Accounts Payable	239.57M	281.87M	418.54M	522.52M	574.14M	483.22M	647.99M	2.05B	2.09B	943.89M
Days Payables Outstanding	35.63	60.28	77.86	88.39	89.9	82.73	101.97	176.55	90.51	65.09
Short-Term Debt	674.99M	247.54M	422.01M	307.29M	187.34M	804.68M	389.92M	2.13M	625.76M	398.02M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	421.57M	92.48M	95.33M	77.81M	58.89M	102.71M	100.72M	145.88M	168.36M	157.15M
Current Ratio	1.13x	2.90x	2.06x	1.69x	1.58x	1.22x	1.06x	1.89x	1.47x	1.95x
Quick Ratio	0.82x	2.51x	1.57x	1.10x	1.03x	0.81x	0.64x	1.13x	0.86x	1.19x
Cash Conversion Cycle	89.56	110.06	106.01	105.59	107.03	107.64	100.48	74.3	72.83	110.85
Total Non-Current Liabilities+	4.6B	3.08B	2.73B	2.64B	4.36B	4.18B	3.29B	4.52B	5.05B	4.44B
Long-Term Debt	3.14B	2.12B	1.42B	1.4B	2.86B	2.77B	2B	3.21B	3.54B	3.12B
Capital Lease Obligations	0	0	0	0	114.69M	116.77M	127M	99.27M	113.68M	99.51M
Deferred Tax Liabilities	736.32M	412.74M	370.39M	382.98M	397.86M	394.85M	353.28M	480.77M	558.43M	358.03M
Other Non-Current Liabilities	1.05B	544.04M	946.4M	858.5M	982.82M	901.5M	809.58M	729.65M	753.95M	789.78M
Total Liabilities	6.21B	4.22B	3.93B	3.82B	5.77B	5.98B	5.17B	7.27B	8.61B	6.41B
Total Debt+	3.82B	2.37B	1.84B	1.71B	3.19B	3.69B	2.52B	3.32B	4.28B	3.62B
Net Debt	3.6B	99.51M	700.07M	1.15B	2.57B	2.94B	2.08B	1.82B	3.39B	2.42B
Debt / Equity	1.12x	0.60x	0.48x	0.45x	0.78x	0.83x	0.43x	0.40x	0.44x	0.35x
Debt / EBITDA	6.31x	2.86x	2.39x	1.53x	3.62x	5.00x	2.40x	1.20x	6.28x	-
Net Debt / EBITDA	5.95x	0.12x	0.91x	1.03x	2.93x	3.99x	1.98x	0.66x	4.97x	-
Interest Coverage	4.23x	9.22x	4.96x	17.39x	11.55x	6.92x	12.99x	20.09x	2.17x	-10.73x
Total Equity+	3.4B	3.94B	3.82B	3.76B	4.09B	4.47B	5.81B	8.19B	9.67B	10.2B
Equity Growth %	1.28%	0.16%	-0.03%	-0.02%	0.09%	0.09%	0.3%	0.41%	0.18%	0.06%
Book Value per Share	30.49	34.82	33.97	34.34	38.50	41.84	49.82	69.54	82.07	86.79
Total Shareholders' Equity	3.25B	3.8B	3.67B	3.59B	3.93B	4.27B	5.63B	7.98B	9.41B	9.96B
Common Stock	1.12M	1.13M	1.1M	1.06M	1.06M	1.07M	1.17M	1.17M	1.17M	1.18M
Retained Earnings	1.62B	2.12B	2.04B	2.57B	2.94B	3.16B	3.1B	5.6B	6.99B	5.48B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-421.29M	-412.41M	-225.67M	-350.68M	-395.74M	-326.13M	-392.45M	-560.66M	-528.53M	-742.06M
Minority Interest	146.92M	147.54M	143.15M	173.79M	161.33M	200.37M	180.34M	208.22M	252.92M	238.17M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	360.69M	733.4M	303.98M	546.16M	719.37M	798.91M	344.26M	1.91B	1.33B	702.07M
Operating CF Margin %	0.1%	0.27%	0.1%	0.16%	0.2%	0.26%	0.1%	0.26%	0.14%	0.13%
Operating CF Growth %	-0.27%	1.03%	-0.59%	0.8%	0.32%	0.11%	-0.57%	4.54%	-0.31%	-0.47%
Net Income	360.06M	680.77M	99.47M	739.14M	604.36M	446.62M	199.94M	2.82B	1.67B	-1.14B
Depreciation & Amortization	260.08M	226.17M	196.93M	200.7M	213.48M	231.98M	254M	300.84M	429.94M	588.64M
Stock-Based Compensation	15.19M	17.03M	19.4M	15.23M	19.68M	22.84M	20.12M	30.47M	36.55M	32.14M
Deferred Taxes	-136.3M	21.12M	-41.94M	49.16M	14.39M	-1.98M	-38.5M	93.34M	100.88M	-230.41M
Other Non-Cash Items	-96.69M	-448.76M	422.38M	-306.1M	-18.2M	185.99M	-203.03M	82.77M	602.75M	88.85M
Working Capital Changes	-41.53M	239.19M	-392.26M	-151.97M	-114.34M	-86.53M	111.72M	-1.41B	-1.52B	1.36B
Change in Receivables	-8.79M	-42.82M	-74.55M	-97.45M	-18.22M	100.12M	-49.3M	-786.12M	-350.65M	555.22M
Change in Inventory	27.65M	25.97M	-101.55M	-124.07M	-46.3M	51.98M	-127.4M	-1.61B	-962.92M	1.56B
Change in Payables	23.75M	43.95M	53.42M	73.73M	-12.23M	-31.52M	143.94M	1.29B	-283.41M	-862.24M
Cash from Investing+	-2.16B	2.92B	-357.8M	-303.69M	-1.66B	-863.57M	-666.59M	-1.42B	-2.78B	-1.57B
Capital Expenditures	-227.65M	-196.65M	-317.7M	-699.99M	-851.8M	-850.48M	-953.67M	-1.26B	-2.15B	-1.69B
CapEx % of Revenue	0.06%	0.07%	0.1%	0.21%	0.24%	0.27%	0.29%	0.17%	0.22%	0.31%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	57.55M	0	0	0	10.36M	0	6.49M	706K	-204.45M	111.62M
Cash from Financing+	-478.32M	-1.58B	-1.09B	-786.53M	1.04B	177.26M	50.21M	611.89M	623.91M	1.24B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-119.3M	-135.35M	-140.56M	-144.6M	-152.2M	-161.82M	-177.85M	-184.43M	-187.19M	-311.28M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-80.87M	-28.65M	-83.85M	-28.36M	-101.34M	-719K	-112.99M	-71.24M	-133.1M	-51.91M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	133.04M	536.75M	-13.72M	-153.83M	-132.42M	-51.56M	-609.41M	646.2M	-823.96M	-983.72M
FCF Margin %	0.04%	0.2%	-0%	-0.05%	-0.04%	-0.02%	-0.18%	0.09%	-0.09%	-0.18%
FCF Growth %	-0.65%	3.03%	-1.03%	-10.21%	0.14%	0.61%	-10.82%	2.06%	-2.28%	-0.19%
FCF per Share	1.19	4.74	-0.12	-1.41	-1.25	-0.48	-5.23	5.49	-7.00	-8.37
FCF Conversion (FCF/Net Income)	1.08x	1.14x	5.54x	0.79x	1.35x	2.13x	2.78x	0.71x	0.84x	-0.60x
Interest Paid	0	0	0	0	0	0	27.73M	92.09M	101.98M	150.69M
Taxes Paid	0	0	0	0	0	0	130.84M	248.14M	319.39M	262.85M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	13.7%	17.53%	1.41%	18.31%	13.58%	8.78%	2.41%	38.44%	17.62%	-11.87%
Return on Invested Capital (ROIC)	5.79%	8.16%	10.02%	14.5%	8.63%	5.39%	7.83%	20.7%	1.64%	-10.38%
Gross Margin	32.78%	36.25%	36.13%	36.07%	35.06%	31.86%	30.3%	42.05%	12.45%	1.57%
Net Margin	9.17%	24.04%	1.79%	20.55%	14.86%	12.01%	3.72%	36.75%	16.36%	-21.93%
Debt / Equity	1.12x	0.60x	0.48x	0.45x	0.78x	0.83x	0.43x	0.40x	0.44x	0.35x
Interest Coverage	4.23x	9.22x	4.96x	17.39x	11.55x	6.92x	12.99x	20.09x	2.17x	-10.73x
FCF Conversion	1.08x	1.14x	5.54x	0.79x	1.35x	2.13x	2.78x	0.71x	0.84x	-0.60x
Revenue Growth	49.31%	-26.68%	14.75%	9.86%	6.35%	-12.83%	6.36%	119.96%	31.38%	-44.08%

Revenue by Segment

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2024
Energy Storage	-	-	-	-	-	-	-	-	-	3.02B
Energy Storage Growth	-	-	-	-	-	-	-	-	-	-
Specialties	-	-	-	-	-	-	-	-	-	1.33B
Specialties Growth	-	-	-	-	-	-	-	-	-	-
Ketjen	-	-	-	-	-	-	-	-	-	1.04B
Ketjen Growth	-	-	-	-	-	-	-	-	-	-
Lithium	-	-	-	-	1.23B	1.36B	1.14B	1.36B	5.01B	-
Lithium Growth	-	-	-	-	-	10.58%	-15.71%	19.09%	267.41%	-
Bromine	-	-	-	-	-	-	-	-	1.41B	-
Bromine Growth	-	-	-	-	-	-	-	-	-	-
Catalysts	-	-	-	-	1.1B	1.06B	797.91M	761.24M	899.57M	-
Catalysts Growth	-	-	-	-	-	-3.61%	-24.85%	-4.60%	18.17%	-
Bromine Specialties	-	-	792.42M	855.14M	917.88M	1B	964.96M	1.13B	-	-
Bromine Specialties Growth	-	-	-	7.91%	7.34%	9.41%	-3.91%	16.93%	-	-
Refining Solutions	-	729.26M	732.14M	778.3M	-	-	-	-	-	-
Refining Solutions Growth	-	-	0.39%	6.31%	-	-	-	-	-	-
Others	-	471.43M	180.99M	128.91M	-	-	-	-	-	-
Others Growth	-	-	-61.61%	-28.77%	-	-	-	-	-	-
Chemetall Surface Treatment	-	824.91M	-	-	-	-	-	-	-	-
Chemetall Surface Treatment Growth	-	-	-	-	-	-	-	-	-	-
Corporate, Non-Segment	-	15.41M	-	-	-	-	-	-	-	-
Corporate, Non-Segment Growth	-	-	-	-	-	-	-	-	-	-
Performance Chemicals	1.35B	-	-	-	-	-	-	-	-	-
Performance Chemicals Growth	-	-	-	-	-	-	-	-	-	-
Catalyst Solutions	1.09B	-	-	-	-	-	-	-	-	-
Catalyst Solutions Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2024
Foreign	1.56B	2.53B	1.88B	2.23B	2.49B	2.73B	2.39B	2.6B	6.43B	4.48B
Foreign Growth	-	62.22%	-25.77%	18.69%	11.48%	9.80%	-12.68%	8.89%	147.63%	-30.41%
UNITED STATES	884.37M	1.12B	797.27M	840.59M	887.42M	858.08M	743.83M	730.74M	888.61M	901.87M
UNITED STATES Growth	-	26.51%	-28.74%	5.43%	5.57%	-3.31%	-13.31%	-1.76%	21.60%	1.49%

Frequently Asked Questions

Growth & Financials

Albemarle Corporation (ALB) reported $4.95B in revenue for fiscal year 2024. This represents a 72% increase from $2.87B in 2011.

Albemarle Corporation (ALB) saw revenue decline by 44.1% over the past year.

Albemarle Corporation (ALB) reported a net loss of $21.2M for fiscal year 2024.

Dividend & Returns

Yes, Albemarle Corporation (ALB) pays a dividend with a yield of 0.92%. This makes it attractive for income-focused investors.

Albemarle Corporation (ALB) has a return on equity (ROE) of -11.9%. Negative ROE indicates the company is unprofitable.

Albemarle Corporation (ALB) generated $104.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Albemarle Corporation (ALB) 10-Year Financial Performance & Capital Metrics

ALB • • Industrial / General

Basic MaterialsSpecialty ChemicalsCatalysts & Process ChemicalsRefining & Petrochemical Catalysts

Revenue $5.38B -44.1%
EBITDA -$1.19B -274.2%
Net Income -$1.18B -175.0%
EPS (Diluted) -11.20 -183.8%
Gross Margin 1.57% -87.4%
EBITDA Margin -22.09% -411.6%
Operating Margin -33.04% -1361.4%
Net Margin -21.93% -234.1%
ROE -11.87% -167.4%
ROIC -10.38% -733.5%
Debt/Equity 0.35 -20.0%
Interest Coverage -10.73 -594.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓14 consecutive years of dividend growth
✓Momentum leader: RS Rating 95 (top 5%)
✓Trading near 52-week high

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y8.2%

5Y8.42%

3Y17.35%

TTM-23.92%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM98.87%

EPS CAGR

10Y-

5Y-

3Y-

TTM90.49%

ROCE

10Y Avg7.25%

5Y Avg5.46%

3Y Avg4.13%

Latest-12.1%

Peer Comparison

Refining & Petrochemical Catalysts

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
IOSPInnospec Inc.	2.03B	81.89	57.67	-5.31%	-0.07%	-0.09%	7.05%	0.04
MTXMinerals Technologies Inc.	2.11B	67.64	13.08	-2.37%	-0.08%	-0.09%	6.98%	0.57
CBTCabot Corporation	3.89B	73.56	12.22	-7.04%	8.91%	19.67%	10.05%	0.66
SSLSasol Limited	4.51B	7.15	0.68	-9.46%	-7.15%	-23.8%	100%	0.77
ALBAlbemarle Corporation	20.45B	173.78	-15.52	-44.08%	-0.43%	-0.21%		0.35
ECVTEcovyst Inc.	1.23B	10.79	-179.83	1.94%	-14.33%	-17.66%	6.58%	1.28

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	3.65B	2.68B	3.07B	3.37B	3.59B	3.13B	3.33B	7.32B	9.62B	5.38B
Revenue Growth %	0.49%	-0.27%	0.15%	0.1%	0.06%	-0.13%	0.06%	1.2%	0.31%	-0.44%
Cost of Goods Sold+	2.45B	1.71B	1.96B	2.16B	2.33B	2.13B	2.32B	4.24B	8.42B	5.29B
COGS % of Revenue	0.67%	0.64%	0.64%	0.64%	0.65%	0.68%	0.7%	0.58%	0.88%	0.98%
Gross Profit+	1.2B	970.58M	1.11B	1.22B	1.26B	996.85M	1.01B	3.08B	1.2B	84.24M
Gross Margin %	0.33%	0.36%	0.36%	0.36%	0.35%	0.32%	0.3%	0.42%	0.12%	0.02%
Gross Profit Growth %	0.55%	-0.19%	0.14%	0.1%	0.03%	-0.21%	0.01%	2.05%	-0.61%	-0.93%
Operating Expenses+	515.12M	369.33M	534.62M	305.72M	592.36M	491.04M	210.04M	607.73M	945.03M	1.86B
OpEx % of Revenue	0.14%	0.14%	0.17%	0.09%	0.17%	0.16%	0.06%	0.08%	0.1%	0.35%
Selling, General & Admin	300.44M	353.76M	450.29M	446.09M	0	0	0	0	0	0
SG&A % of Revenue	0.08%	0.13%	0.15%	0.13%	-	-	-	-	-	-
Research & Development	102.87M	80.47M	84.33M	70.05M	58.29M	59.21M	54.03M	71.98M	85.72M	86.72M
R&D % of Revenue	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	0.01%	0.01%	0.02%
Other Operating Expenses	125.5M	-64.91M	0	-210.43M	534.07M	431.83M	156.01M	535.75M	859.3M	1.77B
Operating Income+	345.11M	600.98M	571.66M	911.54M	666.12M	505.81M	798.43M	2.47B	251.88M	-1.78B
Operating Margin %	0.09%	0.22%	0.19%	0.27%	0.19%	0.16%	0.24%	0.34%	0.03%	-0.33%
Operating Income Growth %	0.27%	0.74%	-0.05%	0.59%	-0.27%	-0.24%	0.58%	2.09%	-0.9%	-8.05%
EBITDA+	605.19M	827.15M	768.59M	1.11B	879.61M	737.8M	1.05B	2.77B	681.83M	-1.19B
EBITDA Margin %	0.17%	0.31%	0.25%	0.33%	0.25%	0.24%	0.32%	0.38%	0.07%	-0.22%
EBITDA Growth %	0.61%	0.37%	-0.07%	0.45%	-0.21%	-0.16%	0.43%	1.63%	-0.75%	-2.74%
D&A (Non-Cash Add-back)	260.08M	226.17M	196.93M	200.7M	213.48M	231.98M	254M	300.84M	429.94M	588.64M
EBIT	392.39M	580.45M	646.62M	749.68M	729.77M	510.47M	621.13M	2.57B	467.11M	-597.75M
Net Interest Income+	-81.65M	-65.18M	-115.35M	-52.41M	-57.7M	-73.12M	-61.48M	-122.97M	-116.07M	-165.62M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	81.65M	65.18M	115.35M	52.41M	57.7M	73.12M	61.48M	122.97M	116.07M	165.62M
Other Income/Expense	-6.39M	-85.72M	-124.86M	-116.84M	26.39M	-4.77M	-569.05M	735.66M	1.85B	728.15M
Pretax Income+	358.19M	515.26M	446.8M	794.7M	692.52M	501.04M	229.39M	3.21B	2.1B	-1.05B
Pretax Margin %	0.1%	0.19%	0.15%	0.24%	0.19%	0.16%	0.07%	0.44%	0.22%	-0.19%
Income Tax+	11.13M	96.26M	431.82M	144.83M	88.16M	54.42M	29.45M	390.59M	430.28M	87.08M
Effective Tax Rate %	0.94%	1.25%	0.12%	0.87%	0.77%	0.75%	0.54%	0.84%	0.75%	1.13%
Net Income+	334.91M	643.67M	54.85M	693.56M	533.23M	375.76M	123.67M	2.69B	1.57B	-1.18B
Net Margin %	0.09%	0.24%	0.02%	0.21%	0.15%	0.12%	0.04%	0.37%	0.16%	-0.22%
Net Income Growth %	1.51%	0.92%	-0.91%	11.64%	-0.23%	-0.3%	-0.67%	20.75%	-0.42%	-1.75%
Net Income (Continuing)	327.59M	478.64M	99.47M	739.14M	604.36M	446.62M	199.94M	2.82B	1.67B	-1.14B
Discontinued Operations	32.48M	202.13M	0	0	0	0	0	0	0	0
Minority Interest	146.92M	147.54M	143.15M	173.79M	161.33M	200.37M	180.34M	208.22M	252.92M	238.17M
EPS (Diluted)+	3.00	5.68	0.49	6.34	5.02	3.52	1.06	22.84	13.36	-11.20
EPS Growth %	0.78%	0.89%	-0.91%	11.94%	-0.21%	-0.3%	-0.7%	20.55%	-0.42%	-1.84%
EPS (Basic)	3.01	5.73	0.49	6.40	5.03	3.53	1.07	22.97	13.41	-11.20
Diluted Shares Outstanding	111.56M	113.24M	112.38M	109.46M	106.32M	106.81M	116.54M	117.79M	117.77M	117.52M
Basic Shares Outstanding	111.18M	112.38M	110.91M	108.43M	105.95M	106.4M	115.84M	117.12M	117.32M	117.52M
Dividend Payout Ratio	0.36%	0.21%	2.56%	0.21%	0.29%	0.43%	1.44%	0.07%	0.12%	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.83B	3.31B	2.48B	2B	2.23B	2.21B	1.99B	5.19B	5.22B	3.84B
Cash & Short-Term Investments	213.73M	2.27B	1.14B	555.32M	613.11M	746.72M	439.27M	1.5B	889.9M	1.19B
Cash Only	213.73M	2.27B	1.14B	555.32M	613.11M	746.72M	439.27M	1.5B	889.9M	1.19B
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	495.55M	543.11M	619.39M	697.89M	752.45M	530.84M	700.06M	1.45B	1.84B	1.07B
Days Sales Outstanding	49.54	74.04	73.59	75.48	76.51	61.92	76.78	72.23	69.65	72.33
Inventory	508.73M	450.26M	592.78M	700.54M	768.98M	750.24M	798.62M	2.08B	2.16B	1.5B
Days Inventory Outstanding	75.65	96.3	110.28	118.5	120.41	128.44	125.67	178.62	93.69	103.61
Other Current Assets	643.6M	1.25M	41.74M	1.5M	6.93M	120.85M	5.8M	6.72M	6.59M	4.75M
Total Non-Current Assets+	7.78B	4.85B	5.27B	5.58B	7.64B	8.24B	8.98B	10.27B	13.05B	12.77B
Property, Plant & Equipment	2.48B	2.36B	2.49B	3.02B	5.04B	5.35B	6.06B	7.09B	9.63B	9.45B
Fixed Asset Turnover	1.47x	1.13x	1.23x	1.12x	0.71x	0.58x	0.55x	1.03x	1.00x	0.57x
Goodwill	2.89B	1.54B	1.61B	1.57B	1.58B	1.67B	1.6B	1.62B	1.63B	1.58B
Intangible Assets	1.73B	354.56M	421.5M	386.14M	354.62M	349.11M	308.95M	287.87M	261.86M	230.75M
Long-Term Investments	455.42M	457.53M	534.06M	528.72M	579.81M	656.24M	912.01M	1.15B	1.38B	1.12B
Other Non-Current Assets	140.97M	81.19M	188.87M	63.11M	63.92M	198.95M	78.7M	75.95M	125.55M	332.26M
Total Assets+	9.62B	8.16B	7.75B	7.58B	9.86B	10.45B	10.97B	15.46B	18.27B	16.61B
Asset Turnover	0.38x	0.33x	0.40x	0.45x	0.36x	0.30x	0.30x	0.47x	0.53x	0.32x
Asset Growth %	0.84%	-0.15%	-0.05%	-0.02%	0.3%	0.06%	0.05%	0.41%	0.18%	-0.09%
Total Current Liabilities+	1.62B	1.14B	1.2B	1.18B	1.41B	1.8B	1.87B	2.74B	3.56B	1.97B
Accounts Payable	239.57M	281.87M	418.54M	522.52M	574.14M	483.22M	647.99M	2.05B	2.09B	943.89M
Days Payables Outstanding	35.63	60.28	77.86	88.39	89.9	82.73	101.97	176.55	90.51	65.09
Short-Term Debt	674.99M	247.54M	422.01M	307.29M	187.34M	804.68M	389.92M	2.13M	625.76M	398.02M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	421.57M	92.48M	95.33M	77.81M	58.89M	102.71M	100.72M	145.88M	168.36M	157.15M
Current Ratio	1.13x	2.90x	2.06x	1.69x	1.58x	1.22x	1.06x	1.89x	1.47x	1.95x
Quick Ratio	0.82x	2.51x	1.57x	1.10x	1.03x	0.81x	0.64x	1.13x	0.86x	1.19x
Cash Conversion Cycle	89.56	110.06	106.01	105.59	107.03	107.64	100.48	74.3	72.83	110.85
Total Non-Current Liabilities+	4.6B	3.08B	2.73B	2.64B	4.36B	4.18B	3.29B	4.52B	5.05B	4.44B
Long-Term Debt	3.14B	2.12B	1.42B	1.4B	2.86B	2.77B	2B	3.21B	3.54B	3.12B
Capital Lease Obligations	0	0	0	0	114.69M	116.77M	127M	99.27M	113.68M	99.51M
Deferred Tax Liabilities	736.32M	412.74M	370.39M	382.98M	397.86M	394.85M	353.28M	480.77M	558.43M	358.03M
Other Non-Current Liabilities	1.05B	544.04M	946.4M	858.5M	982.82M	901.5M	809.58M	729.65M	753.95M	789.78M
Total Liabilities	6.21B	4.22B	3.93B	3.82B	5.77B	5.98B	5.17B	7.27B	8.61B	6.41B
Total Debt+	3.82B	2.37B	1.84B	1.71B	3.19B	3.69B	2.52B	3.32B	4.28B	3.62B
Net Debt	3.6B	99.51M	700.07M	1.15B	2.57B	2.94B	2.08B	1.82B	3.39B	2.42B
Debt / Equity	1.12x	0.60x	0.48x	0.45x	0.78x	0.83x	0.43x	0.40x	0.44x	0.35x
Debt / EBITDA	6.31x	2.86x	2.39x	1.53x	3.62x	5.00x	2.40x	1.20x	6.28x	-
Net Debt / EBITDA	5.95x	0.12x	0.91x	1.03x	2.93x	3.99x	1.98x	0.66x	4.97x	-
Interest Coverage	4.23x	9.22x	4.96x	17.39x	11.55x	6.92x	12.99x	20.09x	2.17x	-10.73x
Total Equity+	3.4B	3.94B	3.82B	3.76B	4.09B	4.47B	5.81B	8.19B	9.67B	10.2B
Equity Growth %	1.28%	0.16%	-0.03%	-0.02%	0.09%	0.09%	0.3%	0.41%	0.18%	0.06%
Book Value per Share	30.49	34.82	33.97	34.34	38.50	41.84	49.82	69.54	82.07	86.79
Total Shareholders' Equity	3.25B	3.8B	3.67B	3.59B	3.93B	4.27B	5.63B	7.98B	9.41B	9.96B
Common Stock	1.12M	1.13M	1.1M	1.06M	1.06M	1.07M	1.17M	1.17M	1.17M	1.18M
Retained Earnings	1.62B	2.12B	2.04B	2.57B	2.94B	3.16B	3.1B	5.6B	6.99B	5.48B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-421.29M	-412.41M	-225.67M	-350.68M	-395.74M	-326.13M	-392.45M	-560.66M	-528.53M	-742.06M
Minority Interest	146.92M	147.54M	143.15M	173.79M	161.33M	200.37M	180.34M	208.22M	252.92M	238.17M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	360.69M	733.4M	303.98M	546.16M	719.37M	798.91M	344.26M	1.91B	1.33B	702.07M
Operating CF Margin %	0.1%	0.27%	0.1%	0.16%	0.2%	0.26%	0.1%	0.26%	0.14%	0.13%
Operating CF Growth %	-0.27%	1.03%	-0.59%	0.8%	0.32%	0.11%	-0.57%	4.54%	-0.31%	-0.47%
Net Income	360.06M	680.77M	99.47M	739.14M	604.36M	446.62M	199.94M	2.82B	1.67B	-1.14B
Depreciation & Amortization	260.08M	226.17M	196.93M	200.7M	213.48M	231.98M	254M	300.84M	429.94M	588.64M
Stock-Based Compensation	15.19M	17.03M	19.4M	15.23M	19.68M	22.84M	20.12M	30.47M	36.55M	32.14M
Deferred Taxes	-136.3M	21.12M	-41.94M	49.16M	14.39M	-1.98M	-38.5M	93.34M	100.88M	-230.41M
Other Non-Cash Items	-96.69M	-448.76M	422.38M	-306.1M	-18.2M	185.99M	-203.03M	82.77M	602.75M	88.85M
Working Capital Changes	-41.53M	239.19M	-392.26M	-151.97M	-114.34M	-86.53M	111.72M	-1.41B	-1.52B	1.36B
Change in Receivables	-8.79M	-42.82M	-74.55M	-97.45M	-18.22M	100.12M	-49.3M	-786.12M	-350.65M	555.22M
Change in Inventory	27.65M	25.97M	-101.55M	-124.07M	-46.3M	51.98M	-127.4M	-1.61B	-962.92M	1.56B
Change in Payables	23.75M	43.95M	53.42M	73.73M	-12.23M	-31.52M	143.94M	1.29B	-283.41M	-862.24M
Cash from Investing+	-2.16B	2.92B	-357.8M	-303.69M	-1.66B	-863.57M	-666.59M	-1.42B	-2.78B	-1.57B
Capital Expenditures	-227.65M	-196.65M	-317.7M	-699.99M	-851.8M	-850.48M	-953.67M	-1.26B	-2.15B	-1.69B
CapEx % of Revenue	0.06%	0.07%	0.1%	0.21%	0.24%	0.27%	0.29%	0.17%	0.22%	0.31%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	57.55M	0	0	0	10.36M	0	6.49M	706K	-204.45M	111.62M
Cash from Financing+	-478.32M	-1.58B	-1.09B	-786.53M	1.04B	177.26M	50.21M	611.89M	623.91M	1.24B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-119.3M	-135.35M	-140.56M	-144.6M	-152.2M	-161.82M	-177.85M	-184.43M	-187.19M	-311.28M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-80.87M	-28.65M	-83.85M	-28.36M	-101.34M	-719K	-112.99M	-71.24M	-133.1M	-51.91M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	133.04M	536.75M	-13.72M	-153.83M	-132.42M	-51.56M	-609.41M	646.2M	-823.96M	-983.72M
FCF Margin %	0.04%	0.2%	-0%	-0.05%	-0.04%	-0.02%	-0.18%	0.09%	-0.09%	-0.18%
FCF Growth %	-0.65%	3.03%	-1.03%	-10.21%	0.14%	0.61%	-10.82%	2.06%	-2.28%	-0.19%
FCF per Share	1.19	4.74	-0.12	-1.41	-1.25	-0.48	-5.23	5.49	-7.00	-8.37
FCF Conversion (FCF/Net Income)	1.08x	1.14x	5.54x	0.79x	1.35x	2.13x	2.78x	0.71x	0.84x	-0.60x
Interest Paid	0	0	0	0	0	0	27.73M	92.09M	101.98M	150.69M
Taxes Paid	0	0	0	0	0	0	130.84M	248.14M	319.39M	262.85M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	13.7%	17.53%	1.41%	18.31%	13.58%	8.78%	2.41%	38.44%	17.62%	-11.87%
Return on Invested Capital (ROIC)	5.79%	8.16%	10.02%	14.5%	8.63%	5.39%	7.83%	20.7%	1.64%	-10.38%
Gross Margin	32.78%	36.25%	36.13%	36.07%	35.06%	31.86%	30.3%	42.05%	12.45%	1.57%
Net Margin	9.17%	24.04%	1.79%	20.55%	14.86%	12.01%	3.72%	36.75%	16.36%	-21.93%
Debt / Equity	1.12x	0.60x	0.48x	0.45x	0.78x	0.83x	0.43x	0.40x	0.44x	0.35x
Interest Coverage	4.23x	9.22x	4.96x	17.39x	11.55x	6.92x	12.99x	20.09x	2.17x	-10.73x
FCF Conversion	1.08x	1.14x	5.54x	0.79x	1.35x	2.13x	2.78x	0.71x	0.84x	-0.60x
Revenue Growth	49.31%	-26.68%	14.75%	9.86%	6.35%	-12.83%	6.36%	119.96%	31.38%	-44.08%

Revenue by Segment

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2024
Energy Storage	-	-	-	-	-	-	-	-	-	3.02B
Energy Storage Growth	-	-	-	-	-	-	-	-	-	-
Specialties	-	-	-	-	-	-	-	-	-	1.33B
Specialties Growth	-	-	-	-	-	-	-	-	-	-
Ketjen	-	-	-	-	-	-	-	-	-	1.04B
Ketjen Growth	-	-	-	-	-	-	-	-	-	-
Lithium	-	-	-	-	1.23B	1.36B	1.14B	1.36B	5.01B	-
Lithium Growth	-	-	-	-	-	10.58%	-15.71%	19.09%	267.41%	-
Bromine	-	-	-	-	-	-	-	-	1.41B	-
Bromine Growth	-	-	-	-	-	-	-	-	-	-
Catalysts	-	-	-	-	1.1B	1.06B	797.91M	761.24M	899.57M	-
Catalysts Growth	-	-	-	-	-	-3.61%	-24.85%	-4.60%	18.17%	-
Bromine Specialties	-	-	792.42M	855.14M	917.88M	1B	964.96M	1.13B	-	-
Bromine Specialties Growth	-	-	-	7.91%	7.34%	9.41%	-3.91%	16.93%	-	-
Refining Solutions	-	729.26M	732.14M	778.3M	-	-	-	-	-	-
Refining Solutions Growth	-	-	0.39%	6.31%	-	-	-	-	-	-
Others	-	471.43M	180.99M	128.91M	-	-	-	-	-	-
Others Growth	-	-	-61.61%	-28.77%	-	-	-	-	-	-
Chemetall Surface Treatment	-	824.91M	-	-	-	-	-	-	-	-
Chemetall Surface Treatment Growth	-	-	-	-	-	-	-	-	-	-
Corporate, Non-Segment	-	15.41M	-	-	-	-	-	-	-	-
Corporate, Non-Segment Growth	-	-	-	-	-	-	-	-	-	-
Performance Chemicals	1.35B	-	-	-	-	-	-	-	-	-
Performance Chemicals Growth	-	-	-	-	-	-	-	-	-	-
Catalyst Solutions	1.09B	-	-	-	-	-	-	-	-	-
Catalyst Solutions Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2024
Foreign	1.56B	2.53B	1.88B	2.23B	2.49B	2.73B	2.39B	2.6B	6.43B	4.48B
Foreign Growth	-	62.22%	-25.77%	18.69%	11.48%	9.80%	-12.68%	8.89%	147.63%	-30.41%
UNITED STATES	884.37M	1.12B	797.27M	840.59M	887.42M	858.08M	743.83M	730.74M	888.61M	901.87M
UNITED STATES Growth	-	26.51%	-28.74%	5.43%	5.57%	-3.31%	-13.31%	-1.76%	21.60%	1.49%

Frequently Asked Questions

Growth & Financials

Albemarle Corporation (ALB) reported $4.95B in revenue for fiscal year 2024. This represents a 72% increase from $2.87B in 2011.

Albemarle Corporation (ALB) saw revenue decline by 44.1% over the past year.

Albemarle Corporation (ALB) reported a net loss of $21.2M for fiscal year 2024.

Dividend & Returns

Yes, Albemarle Corporation (ALB) pays a dividend with a yield of 0.92%. This makes it attractive for income-focused investors.

Albemarle Corporation (ALB) has a return on equity (ROE) of -11.9%. Negative ROE indicates the company is unprofitable.

Albemarle Corporation (ALB) generated $104.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.